Ann Emerg Med:基于指南的临床评估与降钙素原指导下的抗生素使用在治疗肺炎中疗效比较

2020-07-28 MedSci原创 MedSci原创

既往研究已经尝试通过使用普拉克索宁和基于序列临床评估的指南来减少社区获得性肺炎不必要和不必要的长时间抗生素治疗。本研究旨在探究基于指南的临床评估和降钙素原指导的抗生素使用在治疗社区获得性肺炎中的效果。

既往研究已经尝试通过使用普拉克索宁和基于序列临床评估的指南来减少社区获得性肺炎不必要和不必要的长时间抗生素治疗。本研究旨在探究基于指南的临床评估和降钙素原指导的抗生素使用在治疗社区获得性肺炎中的效果。

 

我们于2012年11月至2015年4月在12家法国医院进行了一项随机、多中心试验,纳入了18岁以上社区获得性肺炎的急诊科(ED)患者,将其随机分配到降钙素指导组或临床评估组。根据过去的研究,我们假设连续临床评估将优于降钙素指导的护理。主要结果是抗生素持续时间,次要结果包括抗生素持续时间小于或等于5天的比率,以及意向治疗人群30天的临床成功率和合并严重不良结果。

 

结果,在370名符合条件的患者中,285名(77%)被随机分配到临床评估-(n=143)或降钙素指导的护理(n=142)。中位年龄为67岁(范围18~93岁),40%的患者被认为是肺炎严重指数IV级或V级,降钙素指导组依从性为76%。抗生素持续时间在临床评估组和降钙素指导组之间没有显著差异(中位数分别为9天与10天)。各组临床成功率为92%,严重不良结局率相似(分别为15%与20%)。

 

在ED社区获得性肺炎患者中,基于指南的连续临床评估与降钙素指导的护理相比,并没有减少抗生素暴露。两种策略在抗生素使用时间和临床结果方面相似。

 

原始出处:

 

Emmanuel MontassierFrançois Javaudin, et al., Guideline-Based Clinical Assessment Versus Procalcitonin-Guided Antibiotic Use in Pneumonia: A Pragmatic Randomized Trial. Ann Emerg Med. 2019 Oct;74(4):580-591. doi: 10.1016/j.annemergmed.2019.02.025.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1685169, encodeId=a8e61685169d9, content=<a href='/topic/show?id=9bc05542024' target=_blank style='color:#2F92EE;'>#抗生素使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55420, encryptionId=9bc05542024, topicName=抗生素使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765028091178, createdName=yangfl15, createdTime=Mon Dec 28 22:40:04 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740909, encodeId=5e921e40909a4, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Aug 15 13:40:04 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277900, encodeId=2a7212e7900a4, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610598, encodeId=e9141610598cd, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032588, encodeId=8d7010325881d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Jul 28 13:40:04 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804877, encodeId=57f38048e703, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b17c5403244, createdName=ms1000000788165348, createdTime=Tue Jul 28 12:08:30 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1685169, encodeId=a8e61685169d9, content=<a href='/topic/show?id=9bc05542024' target=_blank style='color:#2F92EE;'>#抗生素使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55420, encryptionId=9bc05542024, topicName=抗生素使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765028091178, createdName=yangfl15, createdTime=Mon Dec 28 22:40:04 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740909, encodeId=5e921e40909a4, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Aug 15 13:40:04 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277900, encodeId=2a7212e7900a4, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610598, encodeId=e9141610598cd, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032588, encodeId=8d7010325881d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Jul 28 13:40:04 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804877, encodeId=57f38048e703, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b17c5403244, createdName=ms1000000788165348, createdTime=Tue Jul 28 12:08:30 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1685169, encodeId=a8e61685169d9, content=<a href='/topic/show?id=9bc05542024' target=_blank style='color:#2F92EE;'>#抗生素使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55420, encryptionId=9bc05542024, topicName=抗生素使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765028091178, createdName=yangfl15, createdTime=Mon Dec 28 22:40:04 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740909, encodeId=5e921e40909a4, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Aug 15 13:40:04 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277900, encodeId=2a7212e7900a4, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610598, encodeId=e9141610598cd, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032588, encodeId=8d7010325881d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Jul 28 13:40:04 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804877, encodeId=57f38048e703, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b17c5403244, createdName=ms1000000788165348, createdTime=Tue Jul 28 12:08:30 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1685169, encodeId=a8e61685169d9, content=<a href='/topic/show?id=9bc05542024' target=_blank style='color:#2F92EE;'>#抗生素使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55420, encryptionId=9bc05542024, topicName=抗生素使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765028091178, createdName=yangfl15, createdTime=Mon Dec 28 22:40:04 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740909, encodeId=5e921e40909a4, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Aug 15 13:40:04 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277900, encodeId=2a7212e7900a4, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610598, encodeId=e9141610598cd, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032588, encodeId=8d7010325881d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Jul 28 13:40:04 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804877, encodeId=57f38048e703, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b17c5403244, createdName=ms1000000788165348, createdTime=Tue Jul 28 12:08:30 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1685169, encodeId=a8e61685169d9, content=<a href='/topic/show?id=9bc05542024' target=_blank style='color:#2F92EE;'>#抗生素使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55420, encryptionId=9bc05542024, topicName=抗生素使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765028091178, createdName=yangfl15, createdTime=Mon Dec 28 22:40:04 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740909, encodeId=5e921e40909a4, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Aug 15 13:40:04 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277900, encodeId=2a7212e7900a4, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610598, encodeId=e9141610598cd, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032588, encodeId=8d7010325881d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Jul 28 13:40:04 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804877, encodeId=57f38048e703, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b17c5403244, createdName=ms1000000788165348, createdTime=Tue Jul 28 12:08:30 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
    2020-07-28 内科新手

    谢谢梅斯提供这么好的信息,学到很多

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1685169, encodeId=a8e61685169d9, content=<a href='/topic/show?id=9bc05542024' target=_blank style='color:#2F92EE;'>#抗生素使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55420, encryptionId=9bc05542024, topicName=抗生素使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=765028091178, createdName=yangfl15, createdTime=Mon Dec 28 22:40:04 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740909, encodeId=5e921e40909a4, content=<a href='/topic/show?id=9c76230166d' target=_blank style='color:#2F92EE;'>#临床评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23016, encryptionId=9c76230166d, topicName=临床评估)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e55d34837992, createdName=12498dabm88暂无昵称, createdTime=Sat Aug 15 13:40:04 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277900, encodeId=2a7212e7900a4, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610598, encodeId=e9141610598cd, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 30 01:40:04 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032588, encodeId=8d7010325881d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Tue Jul 28 13:40:04 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804877, encodeId=57f38048e703, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b17c5403244, createdName=ms1000000788165348, createdTime=Tue Jul 28 12:08:30 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
    2020-07-28 ms1000000788165348

    学到了

    0

相关资讯

多措并举!我国新冠肺炎疫情期间妇幼健康得到有力保障

2020年7月11日是第31个世界人口日,我国今年宣传活动主题为“巩固防控成果,保障妇幼健康”。新冠肺炎疫情发生以来,我国多措并举关爱孕产妇、新生儿等特殊群体,妇幼健康得到有力

Crit Care:早期NIV是否可以减少肺炎引起的早期轻度ARDS患者对有创通气的需求?

我们先前的试验研究表明,与常规给氧相比,无创通气(NIV)减少了 "早期 "轻度急性呼吸窘迫综合征(ARDS,PaO2/FIO2在200~300之间)患者对插管的需求。本研究旨在评估早期NIV是否可以

新冠肺炎疫情防控常态化下,实验室生物安全监管要做到这四点!

目前新冠肺炎疫情防控已进入常态化,为进一步加强常态化下的实验室生物安全监管,国家卫生健康委印发了《国家卫生健康委办公厅关于在新冠肺炎疫情常态化防控中的实验室生物安全监督管理的通知》(以下简称《通知》)

一波未平一波又起,高死亡率肺炎侵袭中亚数国!

正所谓一波未平一波又起,中国的疫情逐渐平息之时,全球多国却面临着新一轮的“疫情冲击”。

Clin Chem:丙种球蛋白在肺炎诊断中的临床作用

目前,关于普钙素在肺炎诊断和治疗中的临床效用仍有争议。

Geriatr Gerontol Int:长期大环内酯类药物治疗似乎并不能预防肺炎的发生

在人口老龄化的国家,老年人肺炎越来越被认为是一个保健问题。长期大环内酯类药物治疗可减少慢性呼吸道疾病的发作,但其对预防肺炎的作用尚未确定。